Extrapulmonary tuberculosis, risk factors and incidence;Gruźlica pozapłucna - ryzyko zachorowania i częstość występowania

Pneumonologia i Alergologia Polska

Volumn 79, Issue 6, 2011, Pages 377-378

  Rowińska Zakrzewska, Ewa ^a  

^a INSTYTUT GRU LICY I CHORÓB P UC   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 80055111855     PISSN: 08677077     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Maher D. The natural history of Mycobacterium tuberculosis infection in adults. W: Schaaf H.S., Zumla A.I. (red.). Tuberculosis. WB Saunders, London 2009; 129-132.
2. Beuidenhout J., Schneider J.W. Pathology and pathogenesis of tuberculosis. W: Schaaf H.S., Zumla A.I. (red.). Tuberculosis. WB Saunders, London 2009; 117-128.
3. Gruźlica i choroby układu oddechowego w Polsce w 2010 roku. Korzeniewska-Koseła M. (red.). Instytut Gruźlicy i Chorób Płuc, Zakład Epidemiologii i Organizacji Walki z Gruźlica{ogonek}, Zakopane-2011.
4. Kruijshaar M.E., Abubakar I. Increase in extrapulmonary tuberculosis in England and Wales 1999-2006. Thorax 2009; 64: 1090-1095.
5. Reuter H., Wood R., Schaaf H.S., Donald P.R. Overview of extrapulmonary tuberculosis in adults and children. W: Schaaf H.S., Zumla A.I. (red.). Tuberculosis. WB Saunders, London 2009; 377-396.
6. Donald P.R., Marais B.J., Barry C.E. Age and the epidemiology and pathogenesis of tuberculosis. Lancet 2010; 375: 1852--1854.
7. Iseman M.D. Extrapulmonary tuberculosis in adults. W: Iseman M.D. (red.). A clinician's guide to tuberculosis. Lippincott, Williams & Wilkins, Baltimore 2000; 145-197.
8. Talavera W., Miranda R., Lessnau M-D.K.L., Klapholz A. Extrapulmonary tuberculosis. W: Friedman L. (red.). Tuberculosis current concepts and treatment. CRC Press, Boca Raton 2000; 139-190.
9. Harris T.G., Li J., Hanna D.B., Munsiff S.S. Changing sociodemographic and clinical characteristics of tuberculosis among HIV-infected patients, New York City, 1992-2005. Clin. Infect. Dis. 2010; 50: 1524-1531.
10. De Cock K.M., Soro B., Coulibaly I.M., Lucas S.B. Tuberculosis and HIV infection in Sub-Saharan Africa. JAMA 1992; 268: 1581-1587.
11. Lin J.N., Lai C.H., Chen Y.H. i wsp. Risk factors to extrapulmonary tuberculosis compared to pulmonary tuberculosis. Int. J. Tuberc. Lung Dis. 2009; 13: 620-625.
12. Kumar D., Humar A. Tuberculosis and transplantation. Battling the opportunist. Clin. Inf. Dis. 2009; 48: 1666-1668.
13. Cointini S., Raimondi G., Graziano P. i wsp. Difficult diagnosis of infliximab-related miliary tuberculosis. Monaldi Arch. Chest Dis. 2004; 61: 128-130.
14. Matsumoto T., Tanaka T., Kawase I. Infliximab for rheumatoid arthritis in a patient with tuberculosis. N. Engl. J. Med. 2006; 355: 740-741.
15. Kim D.K., Park G.M., Hwang Y.I. i wsp. Microarray analysis of gene expression associated with extrapulmonary dissemination of tuberculosis. Respir. 2006; 11: 557-565.
16. Forssbohm M., Zwahlen M., Loddenkemper R., Rieder H.L. Demographic characteristics of patients with extrapulmonary tuberculosis in Germany. Eur. Respir. J. 2008; 31: 99-105.
17. Asghar R.J., Pratt R.H., Kameren S., Navin T.R. Tuberculosis in South Asian living in the United States 1993-2004. Arch. Int. Med. 2008; 168: 936-943.
18. Chand-Yeung M., Noertjojo K., Chan S.L., Tam C.M. Sex differences in tuberculosis in Hong Kong. Int. J. Tuberc. Lung Dis. 2002; 6: 11-18.
19. Baydur A. The spectrum of extrapulmonary tuberculosis. West. J. Med. 1977; 126: 253-262.
20. Weir M.R., Thorton G.F. Extrapulmonary tuberculosis. Am. J. Med. 1985; 79: 467.
21. Rowińska-Zakrzewska E., Szopiński J., Remiszewski P. i wsp. Tuberculosis in the autopsy material: analysis of 1500 autopsies performed between 1972 and 1991 in the Institute of Tuberculosis and Chest Diseases, Warsaw, Poland. Tuberc. Lung Dis. 1995; 76: 349-354.
22. Michałowska-Mitczuk D., Błasińska-Przerwa K. Gruźlica kości ramiennej. Pneumonol. Alergol. Pol. 2011; 6: 437-441.
23. Kim H.A., Yoo C.D., Baek H.J. i wsp. Mycobacterium tuberculosis infection in a corticosteroid-treated rheumatic disease patient population. Clin. Exp. Rheumatol. 1998; 16: 9-13.
24. Falagas M.E., Voidonikola P.T., Angelousi A.G. Tuberculosis in patients with systemic rheumatic or pulmonary diseases treated with glucocorticosteroids and the preventive role of isoniazid: a review of the available evidence. Intern. J. Antimicrob. Agents 2007; 30: 477-486.
25. Jick S.S., Lieberman E.S., Rahman M.U., Choi H.K. Glucocorticoid use, other associated factors, and the risk of tuberculosis. Arthritis & Rheumatism 2006; 55: 19-26.